242 related articles for article (PubMed ID: 32468043)
21. Silencing of
Zhang P; Li Z; Yang G
Int J Mol Med; 2021 Dec; 48(6):. PubMed ID: 34713300
[TBL] [Abstract][Full Text] [Related]
22. miR-202 functions as a tumor suppressor in non-small cell lung cancer by targeting STAT3.
Zhao Z; Lv B; Zhang L; Zhao N; Lv Y
Mol Med Rep; 2017 Aug; 16(2):2281-2289. PubMed ID: 28656198
[TBL] [Abstract][Full Text] [Related]
23. Long Noncoding RNA SNHG6 Promotes Proliferation and Inhibits Apoptosis in Non-small Cell Lung Cancer Cells by Regulating miR-490-3p/RSF1 Axis.
Dong Z; Liu H; Zhao G
Cancer Biother Radiopharm; 2020 Jun; 35(5):351-361. PubMed ID: 32202941
[No Abstract] [Full Text] [Related]
24. miR‑454‑3p inhibits non‑small cell lung cancer cell proliferation and metastasis by targeting TGFB2.
Liao H; Liang Y; Kang L; Xiao Y; Yu T; Wan R
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760169
[TBL] [Abstract][Full Text] [Related]
25. miR‑512‑5p suppresses proliferation, migration and invasion, and induces apoptosis in non‑small cell lung cancer cells by targeting ETS1.
Cao B; Tan S; Tang H; Chen Y; Shu P
Mol Med Rep; 2019 May; 19(5):3604-3614. PubMed ID: 30896817
[TBL] [Abstract][Full Text] [Related]
26. Antitumor effects of hsa‑miR661‑3p on non‑small cell lung cancer in vivo and in vitro.
Lu J; Gu X; Liu F; Rui Z; Liu M; Zhao L
Oncol Rep; 2019 May; 41(5):2987-2996. PubMed ID: 30896844
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-454 inhibits non‑small cell lung cancer cells growth and metastasis via targeting signal transducer and activator of transcription-3.
Liu S; Ge X; Su L; Zhang A; Mou X
Mol Med Rep; 2018 Mar; 17(3):3979-3986. PubMed ID: 29286124
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-16 inhibits the proliferation, migration and invasion of non-small cell lung carcinoma cells by down-regulating matrix metalloproteinase-19 expression.
Tian G; Wang SW; Song M; Hu YF; Cao XN; Ge JW
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5260-5269. PubMed ID: 31298377
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-345 suppresses cell invasion and migration in non-small cell lung cancer by directly targeting YAP1.
Zhang MY; Lin J; Kui YC
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2436-2443. PubMed ID: 30964169
[TBL] [Abstract][Full Text] [Related]
30. Downregulation of miR‑138‑5p promotes non‑small cell lung cancer progression by regulating CDK8.
Xing S; Xu Q; Fan X; Wu S; Tian F
Mol Med Rep; 2019 Dec; 20(6):5272-5278. PubMed ID: 31638208
[TBL] [Abstract][Full Text] [Related]
31. miR‑654‑3p suppresses cell viability and promotes apoptosis by targeting RASAL2 in non‑small‑cell lung cancer.
Xiong J; Xing S; Dong Z; Niu L; Xu Q; Li Y; Liu P; Yang P
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33300072
[TBL] [Abstract][Full Text] [Related]
32. Long non‑coding RNA LUCAT1 contributes to cisplatin resistance by regulating the miR‑514a‑3p/ULK1 axis in human non‑small cell lung cancer.
Shen Q; Xu Z; Xu S
Int J Oncol; 2020 Oct; 57(4):967-979. PubMed ID: 32945379
[TBL] [Abstract][Full Text] [Related]
33. Propofol suppresses growth, migration and invasion of A549 cells by down-regulation of miR-372.
Sun H; Gao D
BMC Cancer; 2018 Dec; 18(1):1252. PubMed ID: 30547768
[TBL] [Abstract][Full Text] [Related]
34. MiRNA-200a-3p suppresses the proliferation, migration and invasion of non-small cell lung cancer through targeting IRS2.
Tan T; Xu XH; Lu XH; Wang XW
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):712-720. PubMed ID: 32016973
[TBL] [Abstract][Full Text] [Related]
35. A novel pathway in NSCLC cells: miR‑191, targeting NFIA, is induced by chronic hypoxia, and promotes cell proliferation and migration.
Zhao J; Qiao CR; Ding Z; Sheng YL; Li XN; Yang Y; Zhu DY; Zhang CY; Liu DL; Wu K; Zhao S
Mol Med Rep; 2017 Mar; 15(3):1319-1325. PubMed ID: 28075452
[TBL] [Abstract][Full Text] [Related]
36. MiR-940 inhibits the progression of NSCLC by targeting FAM83F.
Gu GM; Zhan YY; Abuduwaili K; Wang XL; Li XQ; Zhu HG; Liu CL
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5964-5971. PubMed ID: 30280778
[TBL] [Abstract][Full Text] [Related]
37. miR‑205‑3p promotes lung cancer progression by targeting APBB2.
Xu LB; Xiong J; Zhang YH; Dai Y; Ren XP; Ren YJ; Han D; Wei SH; Qi M
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34165160
[TBL] [Abstract][Full Text] [Related]
38. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
39. miR-140-3p inhibits progression of non-small cell lung cancer by targeting Janus kinase 1.
Hu C; Zou Y; Jing LL
J Biosci; 2020; 45():. PubMed ID: 32345774
[TBL] [Abstract][Full Text] [Related]
40. miR-133b reverses cisplatin resistance by targeting GSTP1 in cisplatin-resistant lung cancer cells.
Lin C; Xie L; Lu Y; Hu Z; Chang J
Int J Mol Med; 2018 Apr; 41(4):2050-2058. PubMed ID: 29328427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
